Drug Type Protein drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism CMYA5 inhibitors(cardiomyopathy associated 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | Preclinical | China | 07 Sep 2024 | |
| Heart Failure | Preclinical | China | 07 Sep 2024 | |
| Heart Failure | Preclinical | China | 07 Sep 2024 |






